SoftOx Solutions AS Share Price Oslo Bors
Equities
NO0010811961
Biotechnology & Medical Research
Sales 2021 | 7.9M 720K 60.03M | Sales 2022 | 7.11M 648K 54.04M | Capitalization | 241M 21.95M 1.83B |
---|---|---|---|---|---|
Net income 2021 | -65M -5.92M -494M | Net income 2022 | -71M -6.47M -539M | EV / Sales 2021 | 64.3 x |
Net cash position 2021 | 56.98M 5.19M 433M | Net cash position 2022 | 6.91M 629K 52.47M | EV / Sales 2022 | 32.9 x |
P/E ratio 2021 |
-8.86
x | P/E ratio 2022 |
-3.39
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 96.54% |
Latest transcript on SoftOx Solutions AS
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Geir Almås
FOU | Founder | - | 21/12/21 |
Harald Sætvedt
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Olav Jarlsby
BRD | Director/Board Member | - | 17/15/17 |
Geir Almås
FOU | Founder | - | 21/12/21 |
Adrian Bignami
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |